Is There a Role for Surgery in the Management of Metastatic Urothelial Cancer? The M. D. Anderson Experience-Reference-Cited by-同舟云学术

Is There a Role for Surgery in the Management of Metastatic Urothelial Cancer? The M. D. Anderson Experience

Published:2004-01 Issue:1 Volume:171 Page:145-148
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

SIEFKER-RADTKE ARLENE O.¹,WALSH GARRETT L.¹,PISTERS LOUIS L.¹,SHEN Y.U.¹,SWANSON DAVID A.¹,LOGOTHETIS CHRISTOPHER J.¹,MILLIKAN RANDALL E.¹

Affiliation:

1. From The Center for Genitourinary Oncology, and Departments of Medical Oncology, Surgical Oncology, and Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference14 articles.

1. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium;Sternberg;J Urol,1988

2. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors;Logothetis;J Clin Oncol,1990

3. Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924;Sternberg;J Clin Oncol,2001

4. Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an Eastern Cooperative Oncology Group trial;Loehrer;J Clin Oncol,1994

5. Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer;Siefker-Radtke;J Clin Oncol,2002

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nachsorge nach Harnableitung;Die Urologie;2024-08-01

2. Management of Oligometastatic and Locally Recurrent Urothelial Carcinoma;Current Oncology Reports;2024-04-11

3. Latin American Consensus for the Evaluation and Treatment of Patients With Metastatic/Locally Advanced Urothelial Carcinoma;JCO Global Oncology;2024-02

4. Die Resektion solitärer Lungenmetastasen des Urothelkarzinom kann das Überleben bei selektionierten Patienten verlängern;Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie;2023-09-05

5. Defining Oligometastatic Bladder Cancer: A Systematic Review;European Urology Open Science;2023-09